Perrigo Company plc [PRGO] vs Elanco Animal Health [ELAN] Detailed Stock Comparison
Perrigo Company plc
NYSE
Loading...
Elanco Animal Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Perrigo Company plc wins in 8 metrics, Elanco Animal Health wins in 11 metrics, with 0 ties. Elanco Animal Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Perrigo Company plc | Elanco Animal Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,818.00 | 21.06 | Elanco Animal Health |
| Price-to-Book Ratio | 0.69 | 1.36 | Perrigo Company plc |
| Debt-to-Equity Ratio | 86.48 | 62.13 | Elanco Animal Health |
| PEG Ratio | -30.50 | -0.18 | Perrigo Company plc |
| EV/EBITDA | 7.50 | 15.29 | Perrigo Company plc |
| Profit Margin (TTM) | -1.85% | 9.68% | Elanco Animal Health |
| Operating Margin (TTM) | 6.43% | 6.85% | Elanco Animal Health |
| EBITDA Margin (TTM) | 6.43% | 6.85% | Elanco Animal Health |
| Return on Equity | -1.32% | 6.83% | Elanco Animal Health |
| Return on Assets (TTM) | 3.26% | 0.98% | Perrigo Company plc |
| Free Cash Flow (TTM) | $244.60M | $380.00M | Elanco Animal Health |
| 1-Year Return | -19.83% | 32.48% | Elanco Animal Health |
| Price-to-Sales Ratio (TTM) | 0.71 | 2.05 | Perrigo Company plc |
| Enterprise Value | $6.48B | $12.88B | Elanco Animal Health |
| EV/Revenue Ratio | 1.50 | 2.87 | Perrigo Company plc |
| Gross Profit Margin (TTM) | 34.36% | 57.45% | Elanco Animal Health |
| Revenue per Share (TTM) | $31 | $9 | Perrigo Company plc |
| Earnings per Share (Diluted) | $-0.43 | $0.88 | Elanco Animal Health |
| Beta (Stock Volatility) | 0.48 | 1.62 | Perrigo Company plc |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Perrigo Company plc vs Elanco Animal Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Perrigo Company plc | -1.75% | -2.60% | -4.19% | -18.51% | -23.06% | -16.35% |
| Elanco Animal Health | -0.05% | -2.15% | 3.79% | 33.24% | 75.19% | 54.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Perrigo Company plc | -19.83% | -42.90% | -51.92% | -86.48% | -67.36% | 54.15% |
| Elanco Animal Health | 32.48% | 41.00% | -30.58% | -45.34% | -45.34% | -45.34% |
News Based Sentiment: Perrigo Company plc vs Elanco Animal Health
Perrigo Company plc
News based Sentiment: MIXED
September presented a mixed bag for Perrigo, with strong analyst support and insider buying offset by a disruptive labor strike and a declining stock price. While the company reaffirmed its financial outlook, the ongoing dispute introduces significant uncertainty, making it a month of conflicting signals for investors.
Elanco Animal Health
News based Sentiment: POSITIVE
September was a strong month for Elanco, marked by impressive financial results, positive analyst sentiment, and a clear commitment to innovation and global expansion. The company exceeded earnings expectations, raised guidance, and saw its stock price reach a new 52-week high, indicating a positive trajectory for investors.
Performance & Financial Health Analysis: Perrigo Company plc vs Elanco Animal Health
| Metric | PRGO | ELAN |
|---|---|---|
| Market Information | ||
| Market Cap | $3.06B | $9.21B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,589,850 | 12,762,070 |
| 90 Day Avg. Volume | 1,881,250 | 9,396,177 |
| Last Close | $21.37 | $18.63 |
| 52 Week Range | $21.03 - $30.93 | $8.02 - $19.08 |
| % from 52W High | -30.91% | -2.36% |
| All-Time High | $215.73 (Apr 06, 2015) | $37.61 (Sep 24, 2018) |
| % from All-Time High | -90.09% | -50.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.05% |
| Quarterly Earnings Growth | -0.01% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.10% |
| Operating Margin (TTM) | 0.06% | 0.07% |
| Return on Equity (TTM) | -0.01% | 0.07% |
| Debt to Equity (MRQ) | 86.48 | 62.13 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $32.50 | $13.64 |
| Cash per Share (MRQ) | $3.30 | $1.09 |
| Operating Cash Flow (TTM) | $366.20M | $572.00M |
| Levered Free Cash Flow (TTM) | $775.95M | $1.21B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Perrigo Company plc vs Elanco Animal Health
| Metric | PRGO | ELAN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,818.00 | 21.06 |
| Forward P/E | 7.14 | 19.71 |
| PEG Ratio | -30.50 | -0.18 |
| Price to Sales (TTM) | 0.71 | 2.05 |
| Price to Book (MRQ) | 0.69 | 1.36 |
| Market Capitalization | ||
| Market Capitalization | $3.06B | $9.21B |
| Enterprise Value | $6.48B | $12.88B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.50 | 2.87 |
| Enterprise to EBITDA | 7.50 | 15.29 |
| Risk & Other Metrics | ||
| Beta | 0.48 | 1.62 |
| Book Value per Share (MRQ) | $32.50 | $13.64 |
Financial Statements Comparison: Perrigo Company plc vs Elanco Animal Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PRGO | ELAN |
|---|---|---|
| Revenue/Sales | $1.06B | $1.24B |
| Cost of Goods Sold | $693.40M | $528.00M |
| Gross Profit | $362.90M | $713.00M |
| Research & Development | $22.00M | $92.00M |
| Operating Income (EBIT) | $55.60M | $85.00M |
| EBITDA | $139.30M | $243.00M |
| Pre-Tax Income | $3.20M | $25.00M |
| Income Tax | $3.70M | $14.00M |
| Net Income (Profit) | $-8.40M | $11.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PRGO | ELAN |
|---|---|---|
| Cash & Equivalents | $409.90M | $539.00M |
| Total Current Assets | $2.53B | $3.61B |
| Total Current Liabilities | $1.07B | $1.39B |
| Long-Term Debt | $3.59B | $4.15B |
| Total Shareholders Equity | $4.36B | $6.78B |
| Retained Earnings | $-2.26B | $-1.87B |
| Property, Plant & Equipment | $1.08B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PRGO | ELAN |
|---|---|---|
| Operating Cash Flow | $-9.20M | $185.00M |
| Capital Expenditures | $-25.50M | $-57.00M |
| Free Cash Flow | $-90.00M | $180.00M |
| Debt Repayment | $-8.80M | $-446.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PRGO | ELAN |
|---|---|---|
| Shares Short | 7.40M | 25.82M |
| Short Ratio | 3.94 | 2.56 |
| Short % of Float | 0.06% | 0.07% |
| Average Daily Volume (10 Day) | 1,589,850 | 12,762,070 |
| Average Daily Volume (90 Day) | 1,881,250 | 9,396,177 |
| Shares Outstanding | 136.43M | 494.45M |
| Float Shares | 136.80M | 492.94M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 1.06% | 1.10% |
Dividend Analysis & Yield Comparison: Perrigo Company plc vs Elanco Animal Health
| Metric | PRGO | ELAN |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.63 | N/A |
| 3-Year Avg Dividend Yield | 0.81% | N/A |
| 3-Year Total Dividends | $1.88 | N/A |
| Ex-Dividend Date | Mar 07, 2024 | N/A |